Amarantus Bioscience Holdings Inc (AMBS)

[JLM27]

Zoom, brick, JP, many thanks. You answered my question immediately. The quality of this board never ceases to amaze me.

Now the next question. In the blog Gerald mentioned the in-licensing transaction, which we now know the drug it's in reference to, and stated that "management believes [it] will attract institutional investors to the Company."

How so? Is the other party to the transaction so renowned/connected that it will lend instant credibility to AMBS? Is the drug so promising that it alone will attract institutional investors? Either way, an impressive comment by Gerald that may have been obscured by all the other impressive comments.